NXT-ID (NASDAQ: $NXTD)
Appoints Robert A. Curtis to Board of Directors
Bioscience veteran brings 35 years of health care
industry experience to the Board
SEBASTIAN,
Florida - July 26, 2018 – (Investorideas.com Newswire) NXT-ID, Inc. (NASDAQ:
NXTD or
the "Company") today announced that Robert A. Curtis, Pharm.D., MBA,
has joined its Board of Directors, effective July 25, 2018. Dr. Curtis, a
35-year veteran of the bioscience industry, will add a wealth of health care
experience to the Board of Directors.
"Robert
a long history of successfully bringing new heathcare technologies to market
and a deep background within the industry," said NXT-ID CEO Gino Pereira.
"His expertise and insights will be particularly valuable to the Board as
we develop and execute strategies to grow our healthcare offerings and expand
the market opportunities for that division of our company."
Dr.
Curtis currently serves as a consultant to emerging technology companies and
serves on the board or as an advisor to a number of private entrepreneurial
companies. He recently served as the Executive Chairman and Director of the
Trudeau Institute in Saranac Lake, NY, as well as Chief Executive Officer of
the Regional Technology Development Corporation of Cape Cod, MA, where he was
responsible for identifying and commercializing technology from the Marine
Biological Laboratory and the Woods Hole Oceanographic Institute.
Dr.
Curtis has been a Founder and CEO of several companies, including HistoRx,
Inc., Cape Aquaculture Technologies, Inc., and Lion Pharmaceuticals/Phoenix
Drug Discovery LLC. He assisted in the founding of Environmental Operating
Solutions, Inc, which applied denitrification technology to wastewater with the
company being sold in 2017. He was Co-founder of and CEO of CombiChem, Inc.,
which was purchased by Dupont Pharmaceuticals and served as founding President
and CEO of MetaMorphix, Inc., a joint venture between Genetics Institute, Inc.
and The Johns Hopkins School of Medicine.
Prior
to these entrepreneurial endeavors, Dr. Curtis held senior management positions
at Pharmacopeia, Inc., Cambridge Neuroscience, Inc., and Pfizer, Inc. He also
served as an Assistant Professor of Pharmacy Practice at the University of
Illinois Medical Center in Chicago. Dr. Curtis holds a Bachelor of Science in
Pharmacy from Massachusetts College of Pharmacy, a Pharm.D. from University of
Missouri, and a Master Business Administration from Columbia University
"I
am very pleased to join such as talented Board and look forward to contributing
to the strategic direction of the company," said Curtis. "My goal will
be working with the other Board members and management team to leverage
NXT-ID's healthcare and other capabilities to bring value for
shareholders."
NXT-
ID, Inc. and Fit Pay, Inc.
NXT-ID, Inc. (NASDAQ: NXTD) provides
a comprehensive platform of technology products and services that enable the
Internet of Things (IoT). With extensive experience in access control,
biometric and behavior-metric identity verification, security and privacy,
encryption and data protection, payments, miniaturization and sensor
technologies, NXT-ID develops and markets groundbreaking solutions for payment
and IoT applications. Its industry-leading technology products and solutions
include MobileBio®, a suite of biometric solutions that secure consumers'
mobile platforms, the Wocket™, a next-generation
smart wallet and the Flye, a digital credit
card developed in collaboration with WorldVentures. NXT-ID includes three
mobile and IoT-related subsidiaries: LogicMark, LLC, a manufacturer
and distributor of non-monitored and monitored personal emergency response
systems ("PERS") sold through dealers/distributors and the United
States Department of Veterans Affairs; Fit Pay, Inc., a proprietary technology platform that delivers end-to-end
solutions to device manufacturers for contactless payment capabilities,
credential management, authentication and other secure services within the IoT
ecosystem, and 3D-ID LLC, which is engaged in biometric identification
and authentication. Learn more about NXT-ID at www.nxt-id.com. NXT-ID Inc.
Corporate Contact: info@nxt-id.com. FitPay® and the
FitPay® Payment Platform are trademarks of Fit Pay, Inc.
Forward-Looking
Statements for NXT-ID:
This press release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. Forward-looking
statements reflect management's current expectations, as of the date of this
press release, and involve certain risks and uncertainties. Forward-looking
statements include statements herein with respect to the successful execution
of the Company's business strategy. The Company's actual results could differ
materially from those anticipated in these forward-looking statements as a
result of various factors. Such risks and uncertainties include, among other
things, our ability to establish and maintain the proprietary nature of our
technology through the patent process, as well as our ability to possibly
license from others patents and patent applications necessary to develop
products; the availability of financing; the Company's ability to implement its
long range business plan for various applications of its technology; the
Company's ability to enter into agreements with any necessary marketing and/or
distribution partners; the impact of competition, the obtaining and maintenance
of any necessary regulatory clearances applicable to applications of the
Company's technology; and management of growth and other risks and
uncertainties that may be detailed from time to time in the Company's reports
filed with the Securities and Exchange Commission.
1.760.468.7273
D.
Van Zant
1.800.665.0411
This news is published on the Investorideas.com Newswire - a
global digital news source for investors and business leaders
Sign up for free news alerts
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced
news, articles and equity research as well as creates original content,
including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investment involves risk and
possible loss of investment. This site is currently compensated for news
publication and distribution, social media and marketing, content creation and
more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: Nxt-ID, Inc. (NXTD) is a long term paid news publication and PR
client of Investorideas.com. Renewed October 1, 2017 - see details at http://www.investorideas.com/About/News/Clientspecifics.asp
